IP Library Granted Patent US 8,551,096
Granted Patent B2
US 8,551,096 · App. 12/778,037 · Granted Oct 8, 2013

Directional delivery of energy and bioactives

Inventors: Mike Perry (Los Altos, CA); Brian D. Conn (San Diego, CA); Rolfe T. Gustus (San Diego, CA); Ronda Schreiber (Poway, CA); Corbett Stone (San Diego, CA); Michael F. Hoey (Shoreview, MN)
Assignee: Boston Scientific Scimed, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,551,096
App. No.
12/778,037
Granted
Oct 8, 2013
Kind
B2
Abstract

Systems and methods are disclosed for the treatment of a target tissue by directionally delivering energy and/or bioactive materials to achieve a therapeutic effect. A balloon catheter system having a balloon portion and a plurality of electrodes may be energized to selectively deliver energy, bioactive materials, or a combination thereof to target tissue including tissues disposed about a lumen. The tissue may be targeted by applying energy, making tissue impedance analysis, and further selectively energizing electrodes through the use of an energy source with a controller.

Claims (36)

1. A system for the treatment of a target tissue by directionally delivering energy and/or bioactive material, the system comprising:

an elongate catheter having a proximal end and a distal end with an axis therebetween, the catheter having a radially expandable balloon near the distal end and an energy delivery surface on the balloon;

a thermally changeable coating having a releasable bioactive material and coupled to the balloon, the thermally changeable coating being oriented to be urged against the target tissue when the balloon expands;

wherein the thermally changeable coating has a coating melting temperature greater than 37° C. so that the thermally changeable coating can undergo a phase change to release the bioactive material from the thermally changeable coating; and

an energy source operatively coupled to the catheter to energize the energy delivery surface so as to heat at least a portion of the thermally changeable coating above the coating melting temperature to melt the portion of the thermally changeable coating and release the bioactive material to the target tissue.

2. The system of claim 1 , wherein the energy delivery surface comprises a plurality of spaced electrodes disposed about the expandable balloon, the energy source operatively coupled to the plurality of electrodes so as to selectively energize electrode pairs to heat portions of the thermally changeable coating between the electrode pairs to release the bioactive material to the target tissue.

3. The system of claim 2 , wherein the electrodes are coated with an insulating material.

4. The system of claim 1 , wherein the balloon is encapsulated by a selectively permeable membrane overlaid by a plurality of circumferentially spaced electrodes.

5. The system of claim 4 , wherein the balloon is configured to receive inflation media comprising bioactive material.

6. The system of claim 1 , further comprising a tissue analyzer configured to characterize the body tissue.

7. The system of claim 6 , wherein the electrode delivery portion is energized to heat the thermally changeable coating to release the bioactive material in response to the characterized body tissue.

8. The system of claim 1 , wherein the electrode delivery portion is energized to heat the body tissue before, during and/or after the delivery of the bioactive material.

9. The system of claim 1 , wherein the thermally changeable coating includes more than one releasable bioactive material, wherein each material may have a different phase change temperature.

10. The system of claim 1 , wherein the bioactive material is selected from at least one of, an antiproliferative, an antithrombin, an immunosuppressant, a lipid, an anti-lipid, a liposome, an anti-inflammatory, an antineoplastic, an antiplatelet, an angiogenic agent, an anti-angiogenic agent, a vitamin, an aptamer, an antimitotic, a metalloproteinase inhibitor, a NO donor, an estradiol, an anti-sclerosing agent, a vasoactive, a growth factor, a beta blocker, an AZ blocker, a hormone, a statin, an antioxidant, a membrane stabilizing agent, a calcium antagonist, a retinoid, a peptide, a lipoprotein, a polypeptide, a polynucleotide encoding polypeptides, a protein, a protein drug, an enzyme, a genetic material, a cell, a chemical solvent, an energy-activated agent, an anti-lymphocyte, an anti-macrophage substance or a combination of any of the above.

11. The system of claim 1 , wherein the bioactive material is attached to a portion of a liposome.

12. The system of claim 1 , wherein the thermally changeable coating is selected from at least one of, polylactic acid, polyglycolic acid, polyvinyl acetate, polyvinyl propylene, hydroxypropyl methylcellulose, methacrylate or a combination of any of the above.

13. The system of claim 1 , wherein the energy source is a RF energy source and the delivery portion is configured to transmit RF energy to release and/or activate at least one bioactive material.

14. The system of claim 1 , wherein the energy source is a light energy source and the delivery portion is configured to transmit light energy to release and/or activate at least one bioactive material.

15. A method for the selective delivery of a releasable bioactive material, the method comprising:

engaging a body tissue disposed about a lumen with a thermally changeable coating by radially expanding a balloon of a catheter, the thermally changeable coating disposed on the balloon;

wherein the thermally changeable coating has a coating melting temperature greater than 37° C. so that the thermally changeable coating can undergo a phase change to release the bioactive material from the thermally changeable coating;

energizing a surface on the balloon to heat at least a portion of the thermally changeable coating above the coating melting temperature and at least partially liquefy the thermally changeable coating; and

releasing the bioactive material from the thermally changeable coating into the body tissue in response to the heating.

16. The method of claim 15 , wherein the delivery portion comprises a plurality of electrodes disposed about the expandable balloon and select electrode pairs are energized to heat and liquefy portions of the thermally changeable coating between the electrode pairs.

17. The method of claim 15 , wherein the body tissue of the lumen includes a diseased portion and select electrode pairs are energized to heat the thermally changeable coating proximate the diseased portion.

18. The method of claim 15 , further comprising characterizing the body tissue to identify body tissue to be treated and selectively heating portions of the thermally changeable coating to release the bioactive material in response to the characterized body tissue to treat the identified body tissue.

19. The method of claim 15 , further comprising heating the body tissue before, during and/or after the delivery of the bioactive material.

20. The method of claim 15 , wherein the bioactive material is selected from at least one of a therapeutic fluid, an anesthetic drug, a therapeutic drug, a small molecule, a gene therapeutic compound, an anti-thrombolytic agent, a lubricant to allow higher temperatures without sticking, an electrically conductive compound to lower the impedance at an electrode, an electrically insulating compound to prevent treatment to tissue that does not need treatment, an electrically conductive compound that is intended to migrate through the endothelial layers of tissue to carry energy to the interstitial layers, or a combination of the above.

21. The method of claim 15 , wherein the delivery portion is energized with RF energy to release and/or activate at least one bioactive material.

22. The method of claim 15 , wherein the delivery portion is energized with laser energy to release and/or activate at least one bioactive material.

23. The method of claim 15 , wherein the delivery portion is energized with ultrasound energy to release and/or activate at least one bioactive material.

24. The method of claim 15 , wherein the delivery portion is energized with microwave energy to release and/or activate at least one bioactive material.

25. A catheter system for bioactive material delivery to a body tissue being disposed about a lumen, the system comprising:

an elongate catheter having a proximal end and a distal end with an axis therebetween, the catheter having a radially expandable balloon near the distal end and a plurality of electrodes disposed along an outer surface of the balloon for transmission of energy;

a plurality of biomolecules having a thermally releasable drug portion and an inert portion covalently bound to the balloon; and

an energy source operatively coupled to a controller to selectively energize the plurality of electrodes so as to heat the biomolecules to release the bioactive material to the body tissue.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded May 10, 2019
From: VESSIX VASCULAR, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 049138/0001 →
CHANGE OF NAME Recorded Apr 6, 2012
From: MINNOW MEDICAL, INC.
To: VESSIX VASCULAR, INC.
Reel/Frame 028008/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2010
From: PERRY, MIKE; CONN, BRIAN D.; GUSTUS, ROLFE T.; SCHREIBER, RONDA; STONE, CORBETT; HOEY, MICHAEL F.
To: MINNOW MEDICAL, INC.
Reel/Frame 024743/0173 →
Continuity (2)
Provisional Application 61177744 · May 13, 2009
Related Publication 20110130708A1 · Jun 2, 2011